ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Recompetitions Of DCT Contracts Okayed

March 3, 1989

In Brief: Waldmann, Fisher Win Top Miken Prizes Of $250,000 Each, Six Others Get $50,000

November 10, 1989

In Brief: Edward Sondik Named Director Of CDC’s National Center for Health Statistics

April 12, 1996

NCAB Committee Reaches Consensus On Organ Systems; DeVita Goes Along

February 4, 1983

Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher

June 13, 1980

RFA On Hepatitis B Virus, Liver Cancer

April 15, 1983